HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab

NCT00349349 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukaemia, Lymphocytic, Chronic

Interventions

DRUG: ofatumumab

Sponsor

GlaxoSmithKline